SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,472.33 879.09
( 1.23%)

Global Indices

Nasdaq

51,671.07 418.43
(0.82%)

Dow Jones

7,831.57 45.21
(0.58%)

Hang Seng

69,084.74 42.63
(0.06%)

Nikkei 225

10,559.70 118.10
(1.13%)

Forex

USD-INR

96.78 0.11
(0.12%)

EUR-INR

108.39 0.07
(0.07%)

GBP-INR

127.86 0.00
(0.00%)

JPY-INR

0.61 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Beryl Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524606

INE415H01017

19.4520575

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

21.39

13.34

EPS(TTM)

Face Value()

Div & Yield %

1.23

Back

Mcleod Russel India reports consolidated net loss of Rs 13.38 crore in the June 2026 quarter

Aug 15,2026

Net Loss of Mcleod Russel India reported to Rs 13.38 crore in the quarter ended June 2026 as against net loss of Rs 43.48 crore during the previous quarter ended June 2025. Sales rose 21.02% to Rs 261.11 crore in the quarter ended June 2026 as against Rs 215.76 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	261.11	215.76	21
OPM %	11.16	3.32	-
PBDT	2.39	-36.72	LP
PBT	-13.33	-51.65	74
NP	-13.38	-43.48	69

72,472.33 879.09 ( 1.23%)

51,671.07 418.43 (0.82%)

7,831.57 45.21 (0.58%)

69,084.74 42.63 (0.06%)

10,559.70 118.10 (1.13%)

96.78 0.11 (0.12%)

108.39 0.07 (0.07%)

127.86 0.00 (0.00%)

0.61 0.00 (0.21%)